ProQR Therapeutics N.V 20-F for FY2022
ProQR Therapeutics N.V. (PRQR)
20-F
2023-03-29
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 20-F
ProQR Therapeutics N.V filed this 20-F on March 29, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 4.04M EUR
- up 198.2% from 1.35M EUR a year earlier
- Net loss
- 65.11M EUR
- compared with a net loss of 61.62M EUR a year earlier
- Diluted EPS
- -0.91 EUR
- compared with -0.96 EUR a year earlier